Precursor proteolysis is a crucial mechanism for regulating protein structure and function. Signal peptidase (SP) is an enzyme with a well-defined role in cleaving N-terminal signal sequences but no demonstrated function in the proteolysis of cellular precursor proteins. We provide evidence that SP mediates intraprotein cleavage of IgSF1, a large cellular immunoglobulin (Ig)-domain protein that is processed into two separate Igdomain proteins. In addition, our results suggest the involvement of signal peptide peptidase (SPP), an intramembrane protease, which acts on substrates that have been previously cleaved by signal peptidase (SP). We show that IgSF1 is processed through sequential proteolysis by SP and SPP. Cleavage is directed by an internal signal sequence and generates two separate Igdomain proteins from a polytopic precursor. Our findings suggest that SP and SPP function are not restricted to N-terminal signal sequence cleavage but also contribute to the processing of cellular transmembrane proteins.
Proteolysis is one of the central mechanisms regulating tissue morphogenesis and cellular functions. Proteolytic processing underlies protein degradation and the regulated release of functionally active protein domains. Classic experiments performed in the 1970's by Blobel and colleagues showed that signal peptidase (SP), an enzyme of the endoplasmic reticulum (ER), cotranslationally cleaves the short leader chains that direct transmembrane and secreted proteins through the ER membrane (see (1) for review). SP is an integral membrane protease that cleaves in the juxtamembrane region of its substrate, removing the membrane-bound signal sequence from its parent protein (2) . SP recognizes small N-terminal sequences that display well-characterized patterns of hydrophobicity and charge (3) .
Recently, a companion enzyme to SP was identified by its ability to cleave membraneembedded signal peptides previously processed by signal peptidase (SP) in the endoplasmic reticulum (ER) (4) . This enzyme was named signal peptide peptidase (SPP), and later shown to be the founding member of a larger protease family.
Only a subset of SP substrates are also substrates for SPP; cleavage requires the presence of polar amino acids in the membrane-spanning sequence (5) . The primary purpose of this intramembrane cleavage event was thought to be the clearance of signal peptides from the ER membrane but cytoplasmic signaling functions of the released peptides have also been proposed (6, 7) . Ablation of SPP in C. elegans, Drosophila and zebrafish is lethal (8) (9) (10) . However, the reason for the lethality is unknown and to date no endogenous non-signal sequence substrates for SPP-cleavage have been identified.
The SPP family of enzymes represent the most recent addition to a class of structurallyrelated intramembrane proteases, including rhomboids, site-2-protease (S2P), and presenilins, which mediate regulated intramembrane proteolysis (RIP), an important theme in proteolysis-dependent cell signaling (11) (12) (13) . Through cleavage within transmembrane domains, these proteases trigger the release of extracellular and intracellular protein domains. Many of these fragments then exert signaling functions that can contribute to a diverse array of processes including cell differentiation, lipid metabolism, cytokine production, and the response to unfolded proteins (14) (15) (16) (17) .
SPP and the several known signal peptide peptidase-like proteins (SPPL) localize to distinct subcellular compartments where they may target different substrates (10, 18) . In contrast to presenilins and rhomboids, which cleave type I oriented transmembrane domains, SPP family proteins target type II oriented membrane domains (15, 18, 19) . For example, the transmembrane domain of the type II oriented TNF is a substrate for cleavage by SPP-like proteins SPPL2a and SPPL2b in endosomes and the plasma membrane (20, 21) Some viruses utilize the proteolytic activity of SP and SPP in the ER for viral polypeptide biosynthesis (22-24). For example, membrane proteins of Semliki Forest Virus are translated as one large polyprotein precursor from which mature p62, 6k and E1 proteins are released by SP cleavage (25). In contrast to signal peptides in cellular proteins, the SP cleavage sites are found not at the N-terminus but rather internally within the polyprotein sequence. Similarly, an internal signal sequence targets the Hepatitis C virus polyprotein to the ER (26) , where the core and envelope proteins are formed by the sequential action of SP and SPP. The envelope protein E1 becomes a transmembrane protein that is targeted to the plasma membrane whereas the core protein is released into the cytoplasmic matrix where it associates with lipid droplets (27) . Despite the small size of the peptide fragment released by SPP, functional SPP cleavage is necessary for productive viral infection in vivo (28) . Since internal cleavable signal sequences are thought to be restricted to viral polyproteins it has been assumed that polyprotein precursors of cellular proteins cannot be similarly converted into functionally distinct proteins by SP and SPP processing.
We investigated the biosynthesis and processing of IgSF1 (p120/inhibin-binding protein), an immunoglobulin (Ig) domain protein that is highly expressed in the pituitary and brain (29) (30) (31) (32) . Several previous findings highlighted potential functions of IgSF1 in cell signaling. Pituitary Igsf1 mRNA levels are dynamically regulated during the rat estrous cycle (29) and the IgSF1 protein has been proposed to associate with TGF receptors (33) . Moreover, in recent studies we observed that IgSF1 expression was dramatically up-regulated in the developing pontocerebellar system during neuronal synapse formation (34) . Sequence analysis suggested that IgSF1 is a type I transmembrane protein with an N-terminal signal sequence, followed by 11 Ig domains, a single transmembrane domain and a short cytoplasmic tail (30-32) (see Fig. 1A ). We show here that two additional hydrophobic domains in the center of the IgSF1 polypeptide act as stop-transfer and internal signal sequences. Sequential proteolytic processing by SP and SPP generates two Ig domain proteins, each with a single transmembrane domain. Our results demonstrate that processing of internal signal sequences is not restricted to viral polyproteins and expand SP and SPP function to the generation of cellular proteins. All animal use was approved by and according to the Institutional Animal Care and Use Committee at Columbia University. IgSF1 mutant -/-mice were bred and genotyped as described previously (35) . Adult mice were sacrificed by CO 2 inhalation. Fresh pituitaries were dissected on ice and solubilized in phosphate-buffered saline (PBS) supplemented with 0.1% SDS, 1% Triton X-100, 5 mM EDTA, 2 mM DTT, and complete protease inhibitor cocktail (Roche). Protein concentration was determined by BCA assay (Pierce) prior to SDS-PAGE analysis.
EXPERIMENTAL PROCEDURES
Protein Analysis Methods -For deglycosylation experiments, the protein concentration of cell lysates was determined by BCA assay (Pierce). For each sample, lysate containing 20 g of protein was denatured in SDS-containing buffer (New England Biolabs) for 10 minutes. Lysates were then treated with 500 units of Endoglycosidase H or PNGase F (New England Biolabs) for 1-2 hours at 37°C and analyzed by western blotting. Since the N-terminal IgSF1 fragment tends to aggregate upon boiling, protein samples were only heated to 37°C before analysis by SDS-PAGE.
(ZLL) 2 -ketone and Compound E (Calbiochem) were added to cells 10-12 hours before analysis at 100 M and 10 nM, respectively. To separate SPP-cleaved and uncleaved N-terminal fragments, protein samples were separated on 15% Tris-Tricine gels.
For pulse-chase analysis, transfected HEK293 cells were starved for two hours in cysteine/methionine-free DMEM (Invitrogen) and then pulsed for 10 minutes with 14.3 Ci of 35 Sradiolabeled cysteine/methionine (Pro-Mix, Amersham Biosciences). Cells were washed once and left in media supplemented with 40 μg/ml each of unlabeled cysteine and methionine. After the indicated chase times, cells were washed once in ice-cold PBS and collected in lysis buffer (PBS, 0.1% SDS, 1% Triton X-100, 5 mM EDTA, 2 mM DTT, Complete protease inhibitor cocktail). Proteins were immunoprecipitated from cleared lysates with control or anti-HA antibodies, antibody complexes were collected with Protein G beads (Amersham Biosciences), beads were washed five times in lysis buffer and precipitated proteins were eluted in Laemmli buffer and separated by SDS-PAGE.
Proteins were visualized by autoradiography.
For immunofluorescence analysis, cells were fixed for 10 min with phosphate-buffered 4% paraformaldehyde. Cells were permeabilized with 0.1% Triton X-100 or left unpermeabilized, blocked for 1 hour with PBS containing 10% goat serum, and incubated with primary antibodies over night at 4°C. For detection, cross-absorbed CY2-and CY3-conjugated secondary antibodies were used (Jackson Immuno Research) and cells were imaged on a Zeiss LSM 510meta confocal microscope.
In vitro translocation assays -Wild-type and 4xY mutant IgSF1, in which four residues near the SPcleavage site have been replaced by tyrosines (see Supplementary Material for details) were synthesized in vitro using 500 ng of plasmid DNA and complete amino acid mix, following the TNT Coupled Reticulocyte Lysate System protocol (Promega). For translocation assays, canine pancreatic microsomes (Promega) were included in the reactions (1.8 l per 25 l reaction; increasing the amount of microsomes did not increase the efficiency of translocation; data not shown). IgSF1-containing TNT lysates were deglycosylated with PNGaseF and EndoH following the manufacturer's protocol, with minor changes. Wild-type TNTIgSF1 (with microsomes) samples were denatured at 100°C for 10 min in the denaturation buffer provided by the manufacturer. 4xY mutant TNT-IGSF1-mut (with microsomes) samples were denatured at 70°C for 20 min to reduce aggregation of the protein.
Proteins were resolved on NuPAGE 4-12% BisTris gradient gels in MOPS buffer (Invitrogen), following the manufacturer's protocol with minor alterations. Deglycosylated samples were re-heated at 37°C prior to loading onto the gels. Nondeglycosylated samples were heated at 70°C for 10 minutes. Proteins were transferred to nitrocellulose membranes (30V, 1hr), and membranes blocked with 5% milk in TBST (0.05% Tween in TBS). Blots were incubated overnight at 4°C in mouseanti-HA (1:40,000, Sigma). The following day, membranes were washed 3 x 15 min in TBST, and incubated with goat-anti-mouse HRP-conjugated secondary antibody for 1 hr at room temperature (BioRad, 1:3,000 in 5% milk). Membranes were washed 3x 15 min in TBST, followed by incubation in Amersham ECL Plus reagent and exposure to Xray film (GE Healthcare).
All experiments described in this study were repeated at least three times. The repetitions yielded highly similar results and the data included in the manuscript are representative for these independent experiments.
RESULTS

IgSF1 is subject to internal proteolytic cleavage.
We raised polyclonal antibodies to study the biosynthesis and processing of IgSF1. Specific antisera were obtained for two peptide epitopes, one located at the mature N-terminus of the protein and one located in the presumptive center of the coding sequences. Surprisingly, affinity-purified antisera detected proteins of different molecular weights from mouse pituitary. The N-terminal domain (NTD) antibody detected a protein migrating at ~60-70 kDa, whereas the central domain (CTD) antibody detected a doublet migrating at ~130-150 kDa. These apparent molecular weights reflect the weights of glycosylated proteins, and thus are larger than the predicted molecular weights as illustrated in the diagram (Fig. 1A) . This fact will be further examined below (Fig. 3) .
Immune-reactivity for both products was absent or strongly reduced in lysates of pituitary tissue from knock-out mice lacking the first (noncoding) exon of the Igsf1 gene (35) , demonstrating the specificity of the antibody detection (Fig. 1B) .
Multiple IgSF1 transcripts have been identified in pituitary (29, 35) . To examine whether the NTD and CTD proteins are the products of separate transcripts or processing of a single polypeptide, we probed cell lysates of HEK293 cells transfected with an expression construct encoding the full length human IgSF1 mRNA (Fig.  1B) . As observed for the endogenous protein, two protein species were generated from this cDNA, strongly supporting the idea that proteolytic processing of an IgSF1 precursor gives rise to the two protein isoforms. We further probed the subcellular localization of the IgSF1 products by immunofluorescence analysis of COS7 cells transfected with the same full-length IgSF1 expression construct (Fig. 1C) . Staining of permeabilized cells with the NTD and CTD antibodies revealed partially non-overlapping localization of these proteins. Whereas both antibodies detected intracellular pools of the protein in the ER, only the CTD antibody detected protein in non-permeabilized cells. This suggests that the N-terminal protein product might be retained intracellularly while the CTD protein is targeted to the plasma membrane.
The apparent processing of IgSF1 was further examined using a dually tagged IgSF1 cDNA ( Fig. 2A) . A myc-tag was introduced after the N-terminal signal sequence and a triple HAepitope was inserted at the C-terminus. Immunoblotting with anti-myc and anti-HA antibodies confirmed that IgSF1 underwent proteolytic cleavage (Fig. 2B) . The HA-tagged (Cterminal) fragment had the same molecular weight as the protein detected with the CTD antibody whereas the myc-tagged fragment corresponded in size to the protein detected by the NTD antibody. Taken together with the findings on the endogenous protein, this indicates that IgSF1 is cleaved into at least two fragments, one containing the C terminus and the other containing the N terminus of the original polyprotein.
Interestingly, the protein fragments also differed in their carbohydrate modifications (Fig. 2B) . A substantial portion of the HA-tagged (C-terminal) protein acquired endoglycosidase H (EndoH)-resistant N-glycans, whereas the glycans on the myc-tagged (Nterminal) protein remained fully EndoH-sensitive consistent with its predicted retention in the ER.
The retention of the NTD in the ER (Fig.  1C) and the lack of EndoH-resistant carbohydrates suggested that cleavage of the IgSF1 precursor protein might occur early in the secretory pathway. To explore the kinetics of IgSF1 precursor cleavage, transfected HEK293 cells were pulsed with radiolabeled methionine and cysteine for 5 minutes and IgSF1 was immunoprecipitated either with antibodies against the C-terminal HA-tag or with a control antibody (Fig. 2C) . Precipitates were treated with either EndoH or peptide-N-glycosidase (PNGase) F to discriminate size variations due to changes in the protein backbone and Nglycosylation.
Even when proteins were precipitated immediately after the pulse (0'), no IgSF1 precursor was recovered. After the 120 min chase, 30% of IgSF1 had acquired complex carbohydrates, indicating transport to the Golgi complex, and approximately 75% had acquired EndoH-resistance in samples metabolically labeled over-night (Fig. 2C) . These findings strongly suggest that proteolytic cleavage of IgSF1 occurs co-translationally or very soon after translation of the full-length protein.
IgSF1 contains an internal signal sequence. Based on the apparent molecular weights of the N-and Cterminal fragments, as well as the location of the epitope localized by the CTD antibody we predicted that the cleavage site should be located within amino acids 400-560 of full length IgSF1. This region contains two hydrophobic domains, the second of which bears strong similarity to that of an N-terminal signal peptide. It contains a positively charged n-region, a central hydrophobic h-region, and a polar carboxy-terminal c-region (predictions with Signal P 3.0, Fig. 3A) (3, 36, 37) . In order to test whether this hydrophobic region was indeed capable of functioning as a signal peptide, we constructed a truncated IgSF1 expression construct (IgSF1-N) where the N-terminal signal sequence, the first five Ig domains and the first hydrophobic domain were deleted (Fig. 3B) . When expressed in COS7 cells, IgSF1-N acquired complex EndoHresistant carbohydrate modifications and was efficiently transported to the plasma membrane (Fig. 3B,C) . This demonstrates that the second internal hydrophobic domain in IgSF1 represents a functional signal sequence when placed at the Nterminus of a protein and is sufficient to direct translocation and subsequent cleavage by SP. We speculated that this sequence also might direct cleavage of the full-length protein.
The internal signal sequence in IgSF1 is sufficient to direct site-specific cleavage of membrane proteins.
To test directly whether the internal signal sequence in IgSF1 is sufficient to confer proteolytic cleavage we generated a series of chimaeric molecules using sequences from IgSF1 and SHPS-1 (SHP-substrate 1, a type I transmembrane protein with an N-terminal signal sequence, three extracellular Ig-domains, and a single transmembrane domain. In the chimaera SHPS1-IgSF1, the two hydrophobic segments and the adjacent c-region of IgSF1 were fused into SHPS-1 (see Fig. 4A ). As a negative control, we transplanted two hydrophobic segments (a stoptransfer and a start-transfer sequence) of the polytopic plasma membrane protein CD47 in the same position (SHPS1-CD47). The hydrophobic domains of IgSF1 were further dissected in three additional chimaeras. In CD47/IgSF1, the second hydrophobic domain of IgSF1 and the adjacent cregion were combined with the stop-transfer sequence of CD47. In IgSF1Dc the c-region of IgSF1 was deleted, and in IgSF1 4xY four amino acids near the predicted SP-cleavage site were mutated to tyrosines.
HEK293 cells were transfected with these constructs, and processing of their protein products was monitored using a C-terminal HA-tag for detection. All samples were de-glycosylated with PNGaseF to eliminate any size differences due to alterations in carbohydrate modifications. Using this detection system, non-cleaved proteins have an apparent molecular weight of 70-80 kDa whereas proteolytic cleavage produces C-terminal fragments of about 55 kDa (see Fig. 4B ).
Analysis of the chimaeric molecules strongly supported the idea that the internal signal sequence in IgSF1 directs site-specific protein processing. Transfer of the two hydrophobic domains and the c-region of IgSF1 into SHPS1 was sufficient to convert SHPS1 into a cleavage substrate. Whereas the first hydrophobic domain of IgSF1 could be replaced by the stop-transfer sequence of CD47 without affecting processing (CD47/IgSF1), cleavage was abolished in chimaeras that contained only CD47 transmembrane domains (CD47) or that lacked the c-region of the internal IgSF1 signal peptide (IgSF1 c). Mutation of amino acids in the c-region of signal sequences has been demonstrated to block processing by SP in several proteins (3, 25) . Importantly, similar mutations in the internal IgSF1 c-region strongly reduced internal cleavage (IgSF1 4xY), supporting the idea that this site is processed by SP or by a closely related enzyme.
IgSF1 is cleaved internally by an ER-localized protein.
To test whether the SP-cleavage site in the internal signal sequence was required for processing of full-length IgSF1 we introduced the 4xY mutation into the human Myc-IgSF1-HA expression vector. The wild-type and mutant constructs were then transfected into CHO cells, and products were analyzed by Western blotting with antibodies to the C-terminal HA-epitope tag. The wild-type construct resulted in a product of ~130 kDa (Fig.4C) , a size similar to the endogenous protein detected with a Cterminal antibody (Fig. 2B) . Instead, the 4xY mutant yielded a protein of ~180-200 kDa, suggesting that the mutation of four amino acids in the internal signal sequence indeed resulted in an inhibition of precursor cleavage. Importantly, the differences in electrophoretic mobility were not due to differences in carbohydrate modifications. Deglycosylated forms of the wild-type protein had an apparent molecular weight of ~90 kDa whereas the 4xY mutant migrated at a size of ~160kDa (Fig.4C) , sizes that are in good agreement with the molecular weights predicted from the amino acid sequence of the protein (see Fig.1A ).
To further examine whether processing of IgSF1 occurs during or soon after ER-translocation we employed in vitro transcription/translation (TNT) assays in presence and absence of microsomes. Products were run on SDS-PAGE and subjected to Western blotting with an HA antibody. In the absence of microsomes, wild-type IgSF1 generated a protein precursor of >150 kDa (see Fig.  4D , lane 2). When microsomes were included in the TNT reaction, we observed a novel band at ~130 kDa (Fig. 4C, lane 3) , with equivalent mobility to the form of the protein observed in CHO cells transfected with the wild-type construct (Fig. 4C,  lane 2) . Importantly, treatment of the proteins from the TNT/microsome assays with EndoH or PNGaseF (Fig. 4D, lanes 4 and 5) caused the disappearance of the ~130 kDa band and the emergence of the ~90 kDa band that was observed with deglycosylated IgSF1 from transfected cells (Fig. 4C, lanes 3 and 4) . These data confirm that in the presence of microsomes (and resident SP), the IgSF1 precursor (lane 2, ~160 kDa) can be cleaved and glycosylated, yielding a ~130 kDa protein (~90 kDa after de-glycosylation).
Expression of the IgSF1 4xY mutant protein in the absence of microsomes yielded a precursor protein of similar mobility as the wildtype protein. However, inclusion of microsomes caused a significant size shift to ~180-200 kDa (Fig.  4D, compare lanes 7 and 8) , consistent with the carbohydrate modification of the protein in microsomes. This protein co-migrated with IgSF1 4xY protein detected in transfected CHO cells (Fig.  4C, lane 6) . These data show that the mutation (4xY) in the putative SP cleavage site inhibits proteolytic processing of full-length IgSF1. Collectively, these data support the hypothesis that IgSF1 is cleaved at an internal site by SP or an SPlike protein within the ER.
IgSF1 is a substrate for intramembrane proteolysis by SPP. Cleavage of the internal signal sequence in IgSF1 is predicted to leave the NTD of the protein attached to two transmembrane domains connected through a short cytoplasmic loop (Fig. 5A) . Recent work on SP processing of N-terminal signal sequences and viral polypeptide precursors revealed a second intramembrane cleavage event mediated by SPP (4, 5) . Interestingly, the second hydrophobic domain of IgSF1 contains several polar amino acids, similar to N-terminal signal sequences that are substrates of SPP (see Fig. 3A ). To test whether IgSF1 sequences would undergo sequential processing by SP followed by SPP we incubated SHPS1-IgSF1 expressing cells with (ZLL) 2 -ketone, a specific inhibitor of SPP (38, 39) . As a negative control, cells were treated with Compound E, an inhibitor of intramembrane proteolysis by the presenilin/ -secretase complex.
Analysis of the N-terminal fragments generated by processing of SHPS1-IgSF1 revealed two specific bands that differed in apparent molecular weight by approximately 1 kDa (Fig.  5B) . (ZLL) 2 -ketone, but not Compound E, resulted in a significant loss of the smaller product, strongly supporting the idea that generation of this smaller protein product requires an SPP-like activity. However, blocking SPP activity had no visible effect on migration of the C-terminal (HA-tagged) fragment of the SHPS1-IgSF1 chimaera. Similarly, we found that cleavage of full length IgSF1 into Nand C-terminal fragments was not significantly altered by (ZLL) 2 -ketone ( Supplementary Fig. 1 ). Interestingly, on overexposed Western blots, we could detect a small amount of apparent full-length IgSF1 (less than 1% of the total protein), which might accumulate due to back-up of protein in the ER membrane. This indicates that the initial cleavage step does not require SPP activity but that an SPP-like activity is required for a subsequent cleavage event in the NTD. In summary, this work reveals sequential processing of a cellular transmembrane protein by SP and SPP activities, which generates two independent Ig-domain proteins from one polytopic transmembrane precursor.
DISCUSSION
This study provides evidence for a novel role for SP activity in the biosynthesis of a cellular Ig-domain protein. The IgSF1 full-length transcript encodes an 11 Ig-domain precursor protein that is targeted to the ER by an N-terminal signal sequence. We demonstrate that a stop-transfer sequence and internal signal sequence located after the first five Ig-domains then direct proteolytic cleavage of the IgSF1 polypeptide, separating the first five from the remaining six extracellular Igdomains. The internal signal sequence subsequently undergoes intramembrane proteolysis mediated by SPP or an SPP-like protein in the ER. This second cleavage event presumably releases the cleaved signal peptide into the cytoplasm, leaving the stop transfer sequence as a single transmembrane domain of the N-terminal IgSF1 isoform. This sequential enzymatic processing event ultimately converts one large polytopic membrane protein into two type I proteins that are further transported independently of each other.
A role for SP and SPP in this sequential proteolytic processing is supported by the following observations. First, immunohistochemical and carbohydrate analyses demonstrate that cleavage occurs in the ER. Second, pulse-chase analysis and in vitro translocation assays indicate that cleavage occurs rapidly after synthesis or co-translationally. Third, when placed at the N-terminus of the central domain, the internal cleavage site of the protein acts like a functional signal sequence. Fourth, mutations that abolish SP cleavage in other proteins also abrogate internal processing of the IgSF1 precursor protein. Interestingly, the sequence of the predicted internal SP cleavage site (see Fig. 3A ) matches exactly the sequence of an IgSF1 N-terminal peptide isolated from bovine pituitary membranes (30) . Chong et al. obtained the sequence N-VLIEETEIVMPTPTKPEL-C by Edman degradation and assumed that this internal sequence was recovered due to non-physiological fragmentation of the protein. Our results strongly suggest that this sequence is in fact the N-terminus of the C-terminal IgSF1 product that results from internal SP cleavage.
The hypothesis that a second cleavage event is mediated by SPP is based on the fact that it occurs after the SP cleavage event and is inhibited by (ZLL) 2 -ketone. SPPL3 is another ER SPP-like protein, that is inhibited by (ZLL) 2 -ketone (10,40). Therefore, it is possible that SPPL3 and not SPP is involved in processing of IgSF1, or that both enzymes participate.
While the C-terminal IgSF1 cleavage product was transported to the cell surface, the Nterminal fragment was primarily detected in the ER. ER retention might be due to slower processing of the N-terminal fragment. Alternatively, this fragment might require association with additional membrane proteins for surface transport. In this case, ER retention would reflect an inability of the protein to pass ER quality control in transfected cells. Recent studies revealed that SPP can associate with misassembled transmembrane domain sequences (41) and that SPP is involved in the dislocation of cellular proteins from the ER (42) . Our analysis of IgSF1 expression in pituitary tissue demonstrates that proteolytic processing of IgSF1 is a normal step in its biogenesis in vivo rather than a response to misfolding, though the limited quality of our antibody reagents has so far precluded histological studies to determine the localization of the N-and C-terminal domains in the pituitary.
Our data on internal signal sequence processing of IgSF1 reveal clear parallels with intramembrane cleavage events in other cellular compartments (11) . Intramembrane cleavage of type I oriented cell surface proteins such as Notch and APP by presenilin/gamma-secretase, as well as type II oriented SREBP by S2P and TNF by SPPL2a and SPPL2b requires an initial cleavage by a shedding protease that removes the extracellular domain. Intramembrane proteolysis follows release of the extracellular domains and is dependent on it (5, 11, 20, 21) . Similarly, full length IgSF1 only becomes a substrate for SPP after SP-cleavage of the internal signal peptide in the luminal face of the ER membrane. Consequently, addition of the SPP inhibitor (ZLL) 2 -ketone was not sufficient to prevent separation of the N-and C-terminal domains of IgSF1 but only inhibited the second processing step of the N-terminal fragment ( Fig. 5 and Supplementary Fig. 1 ).
The purpose of the novel cleavage event identified here remains speculative, since the biological function of IgSF-1 is poorly defined at present. The presence of the C-terminal domain at the cell surface suggests a possible function in cellcell adhesion or signaling. The confinement of the N-terminal domain to the ER membrane in our experiments could suggest any of several possibilities.
First, the N-terminal domain could, as a resident transmembrane ER protein have ER functions.
Second, it could be that, under physiological conditions, the N-terminus is transported out of the ER to the cell surface or to another membrane-bound organelle. Signals which would normally mediate this process in vivo might be lacking in the cultured cell lines used for our studies. Both these cases postulate an independent function of the isolated N-terminus, a possibility we consider likely in view of its size, its status as a substrate for SPP-family cleavage, and its stability sufficient for detection in our experiments. Either of these possibilities would reflect a novel activity of SP in processing a cellular polyprotein. It should be noted that the lack of an obvious phenotype in mice lacking upstream DNA sequences of Igsf1 (35) implies that the function of the N-terminal protein is not required for grossly normal development and reproduction.
Investigations directed towards uncovering more subtle phenotypes in these mice are ongoing.
An interesting question emerging from this work is whether internal signal sequence cleavage might be regulated in response to physiological signals. Whereas regulated cleavage of signal sequence substrates has not been described, it has been proposed that sub-compartmentalization of the ER as well as differential use of signal peptides for translocation could yield functionally distinct protein pools (43, 44) . In our experiments, both for the endogenous protein in vivo and the protein expressed from cDNAs in vitro, we always observed processing of the majority of IgSF1 and did not recover a significant non-cleaved pool of full-length IgSF1. This indicates that under our experimental conditions processing is constitutive. However, further work will be required to clarify whether regulation might occur under different conditions.
In summary, our work highlights an unexpected proteolytic processing of a cellular transmembrane protein dependent on an internal signal sequence. It is plausible that other proteins might be modified by a similar mechanism. Considering the extensive knowledge and powerful computational prediction methods for N-terminal signal sequences (36) new candidate substrates for internal signal sequence cleavage could be identified using bioinformatic approaches.
